Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Cash from Operations (2019 - 2025)

Silo Pharma (SILO) has disclosed Cash from Operations for 7 consecutive years, with 780278.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 14.95% to 780278.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 4661339.0 through Dec 2025, down 21.58% year-over-year, with the annual reading at 4661339.0 for FY2025, 21.58% down from the prior year.
  • Cash from Operations hit 780278.0 in Q4 2025 for Silo Pharma, up from 955493.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 319318.0 in Q1 2021 to a low of 1640300.0 in Q1 2025.
  • Historically, Cash from Operations has averaged 874769.45 across 5 years, with a median of 813672.0 in 2022.
  • Biggest five-year swings in Cash from Operations: plummeted 171.51% in 2021 and later increased 29.04% in 2025.
  • Year by year, Cash from Operations stood at 773871.0 in 2021, then fell by 14.49% to 885989.0 in 2022, then fell by 2.71% to 910012.0 in 2023, then dropped by 0.82% to 917432.0 in 2024, then increased by 14.95% to 780278.0 in 2025.
  • Business Quant data shows Cash from Operations for SILO at 780278.0 in Q4 2025, 955493.0 in Q3 2025, and 1285268.0 in Q2 2025.